K
Kathryn Beal
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 127
Citations - 6270
Kathryn Beal is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 38, co-authored 105 publications receiving 4957 citations. Previous affiliations of Kathryn Beal include Cornell University.
Papers
More filters
Journal ArticleDOI
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Paul W. Sperduto,T. Jonathan Yang,Kathryn Beal,Hubert Y. Pan,Paul D. Brown,Ananta S Bangdiwala,Ryan Shanley,Norman Yeh,Laurie E. Gaspar,Steve Braunstein,Penny K. Sneed,John M Boyle,John P. Kirkpatrick,Kimberley S. Mak,Helen A. Shih,Alex Engelman,David Roberge,Nils D. Arvold,Brian M. Alexander,Mark M. Awad,Joseph N. Contessa,Veronica Chiang,J.G. Hardie,Daniel J. Ma,Emil Lou,William Sperduto,Minesh P. Mehta +26 more
TL;DR: The updated Lung-molGPA incorporating gene alteration data into the DS-GPA is a user-friendly tool that may facilitate clinical decision making and appropriate stratification of future clinical trials.
Journal ArticleDOI
Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas.
Philip H. Gutin,Philip H. Gutin,Fabio M. Iwamoto,Kathryn Beal,Nimish Mohile,Sasan Karimi,Bob L. Hou,Stella C. Lymberis,Yoshiya Yamada,Jenghwa Chang,Lauren E. Abrey +10 more
TL;DR: Radiographic responses, duration of disease control, and survival suggest that this regimen is active in recurrent malignant glioma.
Journal ArticleDOI
Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
Ana P. Kiess,Ana P. Kiess,Jedd D. Wolchok,Christopher A. Barker,Michael A. Postow,Viviane Tabar,Jason T. Huse,Timothy A. Chan,Yoshiya Yamada,Kathryn Beal +9 more
TL;DR: Overall, the combination of Ipi and SRS appears to be well tolerated and associated with favorable locoregional control and possibly longer survival in patients with metastatic melanoma.
Journal ArticleDOI
Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
William J. Magnuson,Nataniel H. Lester-Coll,Abraham J. Wu,T. Jonathan Yang,Natalie A. Lockney,Naamit K. Gerber,Kathryn Beal,Arya Amini,Tejas Patil,Brian D. Kavanagh,D. Ross Camidge,Steven E Braunstein,Lauren Boreta,Suresh Kumar Balasubramanian,Manmeet Ahluwalia,Niteshkumar G Rana,Albert Attia,Scott N. Gettinger,Joseph N. Contessa,James B. Yu,Veronica Chiang +20 more
TL;DR: It is demonstrated that the use of upfront EGFR-TKI, and deferral of radiotherapy, is associated with inferior OS in patients with EGfr-mutant NSCLC who develop brain metastases and an urgently needed prospective, multi-institutional randomized trial is urgently needed.
Journal ArticleDOI
Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis
Kimberly L. Johung,Norman Yeh,Neil Desai,Terence M. Williams,Tim Lautenschlaeger,Nils D. Arvold,Matthew S. Ning,Albert Attia,Christine M. Lovly,Sarah B. Goldberg,Kathryn Beal,James B. Yu,Brian D. Kavanagh,Veronica Chiang,D. Ross Camidge,Joseph N. Contessa +15 more
TL;DR: Patients with brain metastases from ALK-rearranged NSCLC treated with radiotherapy (SRS and/or WBRT) and TKIs have prolonged survival, suggesting that interventions to control intracranial disease are critical.